Stelara and Vancomycin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Stelara (ustekinumab) and Vancomycin (vancomycin). Common drug interactions include pleural effusion among females and intestinal haematoma among males.
The phase IV clinical study analyzes what interactions people have when they take Stelara and Vancomycin. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.
What is Stelara?
Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.
What is Vancomycin?
Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.
28 people who take Stelara and Vancomycin together, and have interactions are studied.

What are the common drug interactions of Stelara and Vancomycin, by gender? *:
female:
- Pleural effusion (water on the lungs)
- Productive cough
- Pruritus (severe itching of the skin)
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
- Rash
- Rash pruritic (redness with itching)
- Rectal abscess (pus in rectum)
- Red blood cell sedimentation rate increased
- Respiratory tract congestion (blockage on respiratory system)
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
male:
- Intestinal haematoma (collection of blood, usually clotted, in intestine)
- Abdominal pain
- Fatigue (feeling of tiredness)
- Haematochezia (passage of stools containing blood)
- Iron deficiency
- Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
- Anaphylactic reaction (serious allergic reaction)
- Cardiac arrest
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Clostridium test positive
What are the common drug interactions of Stelara and Vancomycin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Intestinal haematoma (collection of blood, usually clotted, in intestine)
- Haematochezia (passage of stools containing blood)
- Pyrexia (fever)
- Abdominal pain
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Injection site pain
20-29:
n/a
30-39:
- Diarrhoea
- Hypertransaminasaemia
- Liver abscess (pus in liver)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Anal abscess
- Anal fistula
- Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
- Anaphylactic reaction (serious allergic reaction)
- Clostridium test positive
40-49:
- Intestinal obstruction
- Rectal abscess (pus in rectum)
- Abdominal pain
- Cholangitis sclerosing (infection and obstruction of bile duct)
- Nausea (feeling of having an urge to vomit)
50-59:
- Abdominal pain
- Aspartate aminotransferase increased
- Asthenia (weakness)
- Asthma
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Blood parathyroid hormone decreased
- Blood pressure decreased
- Body temperature decreased
- Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
- C-reactive protein increased
60+:
- Ill-defined disorder
What are the existing conditions these people have? *
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 16 people, 57.14%
- Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 11 people, 39.29%
- Pain: 7 people, 25.00%
- Diarrhea: 6 people, 21.43%
- Abdominal Pain: 5 people, 17.86%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 5 people, 17.86%
- Bacteraemia (presence of bacteria in the blood): 5 people, 17.86%
- Asthma: 5 people, 17.86%
- Gallstones (stone formation by bile component): 4 people, 14.29%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Stelara and Vancomycin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Stelara (96,053 reports)
- Vancomycin (17,165 reports)
Browse all drug interactions of Stelara and Vancomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Stelara:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vancomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Stelara and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vancomycin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ustekinumab and vancomycin (the active ingredients of Stelara and Vancomycin, respectively), and Stelara and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Penicillin and Rifampin - a second ago
- Sinusitis - Acute and Tendon Rupture - a second ago
- How effective is Dutoprol for High Blood Pressure? - 4 seconds ago
- Drug interactions of Penicillin and Demerol - 7 seconds ago
- Drug interactions of Amitiza and Temaz - 8 seconds ago
- Could Moxifloxacin cause Ear Discomfort? - 14 seconds ago
- Could Moxifloxacin Hydrochloride cause Fall? - 17 seconds ago
- Drug interactions of Promethazine and Metaxalone - 18 seconds ago
- Drug interactions of Celebrex and Zolmitriptan - 18 seconds ago
- Could Oxycontin cause Haemorrhage Subcutaneous? - 20 seconds ago